Apollon Wealth Management LLC Increases Holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Apollon Wealth Management LLC lifted its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 29.9% in the 3rd quarter, HoldingsChannel reports. The firm owned 13,035 shares of the pharmacy operator’s stock after purchasing an additional 2,998 shares during the quarter. Apollon Wealth Management LLC’s holdings in Walgreens Boots Alliance were worth $117,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also recently modified their holdings of WBA. Iron Horse Wealth Management LLC raised its position in Walgreens Boots Alliance by 162.5% during the second quarter. Iron Horse Wealth Management LLC now owns 2,100 shares of the pharmacy operator’s stock valued at $25,000 after acquiring an additional 1,300 shares in the last quarter. Blue Trust Inc. raised its position in Walgreens Boots Alliance by 87.0% during the second quarter. Blue Trust Inc. now owns 2,324 shares of the pharmacy operator’s stock valued at $28,000 after acquiring an additional 1,081 shares in the last quarter. Continuum Advisory LLC raised its position in Walgreens Boots Alliance by 71.2% during the second quarter. Continuum Advisory LLC now owns 2,453 shares of the pharmacy operator’s stock valued at $30,000 after acquiring an additional 1,020 shares in the last quarter. Sentry Investment Management LLC purchased a new position in Walgreens Boots Alliance during the third quarter valued at approximately $30,000. Finally, Eastern Bank purchased a new stake in shares of Walgreens Boots Alliance in the third quarter valued at approximately $33,000. 58.59% of the stock is currently owned by hedge funds and other institutional investors.

Walgreens Boots Alliance Price Performance

NASDAQ:WBA opened at $8.66 on Tuesday. Walgreens Boots Alliance, Inc. has a 52 week low of $8.20 and a 52 week high of $27.05. The company has a quick ratio of 0.37, a current ratio of 0.68 and a debt-to-equity ratio of 0.67. The company has a market capitalization of $7.49 billion, a P/E ratio of -0.87, a P/E/G ratio of 1.11 and a beta of 0.69. The stock’s fifty day moving average is $9.18 and its two-hundred day moving average is $11.76.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings data on Tuesday, October 15th. The pharmacy operator reported $0.39 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.36 by $0.03. The firm had revenue of $37.50 billion for the quarter, compared to the consensus estimate of $35.75 billion. Walgreens Boots Alliance had a positive return on equity of 14.23% and a negative net margin of 5.85%. The company’s quarterly revenue was up 5.9% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.67 EPS. Equities analysts expect that Walgreens Boots Alliance, Inc. will post 1.53 EPS for the current year.

Walgreens Boots Alliance Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, December 12th. Investors of record on Monday, November 18th will be issued a $0.25 dividend. The ex-dividend date is Monday, November 18th. This represents a $1.00 annualized dividend and a dividend yield of 11.55%. Walgreens Boots Alliance’s dividend payout ratio is presently -9.99%.

Analysts Set New Price Targets

WBA has been the subject of a number of recent analyst reports. Bank of America cut their price objective on Walgreens Boots Alliance from $11.00 to $7.50 and set an “underperform” rating for the company in a research report on Wednesday, September 4th. UBS Group lifted their price target on Walgreens Boots Alliance from $9.00 to $10.00 and gave the stock a “neutral” rating in a research note on Thursday, October 17th. TD Cowen lowered their price target on Walgreens Boots Alliance from $16.00 to $14.00 and set a “buy” rating on the stock in a research note on Tuesday, October 22nd. Evercore ISI lifted their price target on Walgreens Boots Alliance from $7.50 to $10.00 and gave the stock an “in-line” rating in a research note on Wednesday, October 16th. Finally, Jefferies Financial Group lowered their price target on Walgreens Boots Alliance from $19.00 to $9.00 and set a “hold” rating on the stock in a research note on Wednesday, October 23rd. Four research analysts have rated the stock with a sell rating, nine have issued a hold rating and two have given a buy rating to the company. According to MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $12.88.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.